Vickers Philip J.

Director at Akebia Therapeutics, Inc. · on record since Apr 3, 2026
Director at Revance Therapeutics, Inc. · on record since Mar 2, 2015
Director at IT&E INTERNATIONAL GROUP · on record since Jan 9, 2019

Insider trading activity of Vickers Philip J.

Transactions on record: 27; since Mar 2, 2015

Open-market buys: 3; $138.5K

Open-market sells: 0

Companies traded: 3; last filing Apr 3, 2026

Figures computed from official regulatory filings — methodology.

Companies where Vickers Philip J. has traded

Akebia Therapeutics, Inc.1 tx · Apr 3, 2026
IT&E INTERNATIONAL GROUP8 tx · $40.1K · Jun 8, 2023
Revance Therapeutics, Inc.18 tx · $98.4K · May 13, 2022

Track record of Vickers Philip J.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Vickers Philip J.

Co-insiders of Vickers Philip J.

Ostrowski ErikAkebia Therapeutics, Inc. +1
ADAMS ADRIANAkebia Therapeutics, Inc.
Adox James RAkebia Therapeutics, Inc.
ALBERTS KELLYIT&E INTERNATIONAL GROUP
ALLOCCA TONYIT&E INTERNATIONAL GROUP
Allouche CyrilRevance Therapeutics, Inc.
Amello JasonAkebia Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Akebia Therapeutics, Inc.	Apr 3, 2026	AwardD	214,400	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 8, 2023	AwardD	17,643	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 10, 2022	AwardD	17,478	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 10, 2022	AwardD	17,478	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 13, 2022	AwardD	10,756	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 6, 2022	Award	6,059	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 6, 2022	AwardD	11,343	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jul 8, 2021	Buy	4,800	8.35 USD	$40.1K	SEC
IT&E INTERNATIONAL GROUP	Jun 14, 2021	AwardD	17,438	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 7, 2021	AwardD	7,551	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 7, 2021	Award	4,013	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 5, 2020	AwardD	14,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 15, 2020	Award	6,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 15, 2020	AwardD	12,000	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 13, 2019	AwardD	9,675	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 10, 2019	Award	4,500	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 10, 2019	AwardD	9,000	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jan 9, 2019	AwardD	18,743	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 11, 2018	AwardD	6,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 11, 2018	Award	3,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	Mar 16, 2018	Buy	900	31.20 USD	$28.1K	SEC
Revance Therapeutics, Inc.	Mar 16, 2018	Buy	2,250	31.25 USD	$70.3K	SEC
Revance Therapeutics, Inc.	May 12, 2017	AwardD	6,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 12, 2017	Award	3,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 9, 2016	AwardD	8,000	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Akebia Therapeutics, Inc.	Apr 3, 2026	AwardD	214,400	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 8, 2023	AwardD	17,643	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 10, 2022	AwardD	17,478	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 10, 2022	AwardD	17,478	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 13, 2022	AwardD	10,756	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 6, 2022	Award	6,059	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 6, 2022	AwardD	11,343	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jul 8, 2021	Buy	4,800	8.35 USD	$40.1K	SEC
IT&E INTERNATIONAL GROUP	Jun 14, 2021	AwardD	17,438	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 7, 2021	AwardD	7,551	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 7, 2021	Award	4,013	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 5, 2020	AwardD	14,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 15, 2020	Award	6,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 15, 2020	AwardD	12,000	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jun 13, 2019	AwardD	9,675	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 10, 2019	Award	4,500	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 10, 2019	AwardD	9,000	0.00 USD	$0	SEC
IT&E INTERNATIONAL GROUP	Jan 9, 2019	AwardD	18,743	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 11, 2018	AwardD	6,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 11, 2018	Award	3,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	Mar 16, 2018	Buy	900	31.20 USD	$28.1K	SEC
Revance Therapeutics, Inc.	Mar 16, 2018	Buy	2,250	31.25 USD	$70.3K	SEC
Revance Therapeutics, Inc.	May 12, 2017	AwardD	6,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 12, 2017	Award	3,000	0.00 USD	$0	SEC
Revance Therapeutics, Inc.	May 9, 2016	AwardD	8,000	0.00 USD	$0	SEC